Agilent Technologies, Inc. $A Stock Position Cut by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 597,641 shares of the medical research company’s stock after selling 17,741 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Agilent Technologies were worth $102,980,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Agilent Technologies during the 3rd quarter valued at $14,877,000. ProShare Advisors LLC grew its position in Agilent Technologies by 28.4% during the 3rd quarter. ProShare Advisors LLC now owns 60,084 shares of the medical research company’s stock worth $10,353,000 after acquiring an additional 13,273 shares during the last quarter. Vise Technologies Inc. grew its position in Agilent Technologies by 9.5% during the 3rd quarter. Vise Technologies Inc. now owns 10,750 shares of the medical research company’s stock worth $1,852,000 after acquiring an additional 929 shares during the last quarter. Americana Partners LLC increased its holdings in Agilent Technologies by 40.6% in the 3rd quarter. Americana Partners LLC now owns 4,064 shares of the medical research company’s stock worth $700,000 after purchasing an additional 1,173 shares in the last quarter. Finally, Parcion Private Wealth LLC increased its holdings in Agilent Technologies by 14.8% in the 3rd quarter. Parcion Private Wealth LLC now owns 4,932 shares of the medical research company’s stock worth $850,000 after purchasing an additional 634 shares in the last quarter. Institutional investors own 87.41% of the company’s stock.

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Piper Sandler increased their target price on Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research report on Friday, August 28th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. Stifel Nicolaus boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. HSBC upped their price objective on Agilent Technologies from $165.00 to $175.00 and gave the company a “buy” rating in a research note on Tuesday, September 1st. Finally, Barclays upped their price objective on Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $181.45.

Agilent Technologies Price Performance

A stock opened at $172.01 on Tuesday. The company has a market capitalization of $48.49 billion, a P/E ratio of 33.86, a PEG ratio of 2.90 and a beta of 1.21. The company has a fifty day moving average price of $164.37 and a 200-day moving average price of $136.54. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $182.99.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter in the previous year, the firm posted $1.37 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were issued a dividend of $0.2550 per share. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.